Published in Chest on February 01, 2005
Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci U S A (2009) 3.35
Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis (2010) 2.58
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev (2012) 2.11
Persistence of nontuberculous mycobacteria in a drinking water system after addition of filtration treatment. Appl Environ Microbiol (2006) 1.15
Management of nontuberculous mycobacterial infection in the elderly. Eur J Intern Med (2014) 1.04
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease. J Korean Med Sci (2016) 0.96
Hypersensitivity pneumonitis-like granulomatous lung disease with nontuberculous mycobacteria from exposure to hot water aerosols. Environ Health Perspect (2006) 0.94
Comparison of methods for processing drinking water samples for the isolation of Mycobacterium avium and Mycobacterium intracellulare. Appl Environ Microbiol (2008) 0.93
Survival of Mycobacterium avium in drinking water biofilms as affected by water flow velocity, availability of phosphorus, and temperature. Appl Environ Microbiol (2007) 0.91
Coaggregation occurs amongst bacteria within and between biofilms in domestic showerheads. Biofouling (2013) 0.88
Effects of biocides and other metal removal fluid constituents on Mycobacterium immunogenum. Appl Environ Microbiol (2009) 0.87
Hot tub lung mimicking classic acute and chronic hypersensitivity pneumonitis: two case reports. Can Respir J (2007) 0.84
Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis. Thorax (2007) 0.82
Cloning and characterization of CYP51 from Mycobacterium avium. Am J Respir Cell Mol Biol (2006) 0.80
Detection of Legionella, L. pneumophila and Mycobacterium avium complex (MAC) along potable water distribution pipelines. Int J Environ Res Public Health (2014) 0.79
Role of Hot Water System Design on Factors Influential to Pathogen Regrowth: Temperature, Chlorine Residual, Hydrogen Evolution, and Sediment. Environ Eng Sci (2013) 0.78
Lessons from Mycobacterium avium complex-associated pneumonitis: a case report. J Med Case Rep (2008) 0.78
Mycobacterium avium complex in day care hot water systems, and persistence of live cells and DNA in hot water pipes. Curr Microbiol (2013) 0.77
Chronic hypersensitivity pneumonitis. J Asthma Allergy (2016) 0.77
Nontuberculous mycobacterial hypersensitivity pneumonitis related to a home shower: treatment and secondary prevention. BMJ Case Rep (2011) 0.76
Opportunistic Pathogens Mycobacterium Avium Complex (MAC) and Legionella spp. Colonise Model Shower. Pathogens (2015) 0.76
A case of familial hot tub lung. Respir Med Case Rep (2016) 0.75
Mycobacterium gordonae-induced humidifier lung. BMC Pulm Med (2015) 0.75
Characterization of clinical and environmental Mycobacterium avium spp. isolates and their interaction with human macrophages. PLoS One (2012) 0.75
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med (2007) 33.18
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med (2003) 14.40
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev (2006) 7.85
Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev (2002) 7.15
T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med (2009) 7.11
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med (2002) 5.42
Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med (2002) 4.75
Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med (2002) 4.65
Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med (2002) 4.14
Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis (2011) 3.62
Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med (2007) 3.32
Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis (2003) 3.27
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med (2006) 3.20
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med (2010) 3.18
Spotted long oligonucleotide arrays for human gene expression analysis. Genome Res (2003) 2.95
A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother (2009) 2.92
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J (2013) 2.80
Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med (2004) 2.75
Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol (2009) 2.58
Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J (2012) 2.57
Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis (2003) 2.37
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2006) 2.34
Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis (2007) 2.33
Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med (2014) 2.29
Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest (2008) 2.27
Yield of sputum induction in the diagnosis of pleural tuberculosis. Am J Respir Crit Care Med (2003) 2.15
Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol (2011) 2.13
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev (2012) 2.11
Linezolid for multidrug-resistant tuberculosis. Lancet Infect Dis (2012) 2.00
A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med (2005) 1.96
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. Am J Respir Crit Care Med (2012) 1.94
Use of the MGB Eclipse system and SmartCycler PCR for differentiation of Mycobacterium chelonae and M. abscessus. J Clin Microbiol (2005) 1.75
Sequence-based identification of aerobic actinomycetes. J Clin Microbiol (2004) 1.70
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2015) 1.68
Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach. Clin Infect Dis (2005) 1.63
Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol (2004) 1.61
Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med (2012) 1.59
Impact of brief or extended exercise training on the benefit of a dyspnea self-management program in COPD. J Cardiopulm Rehabil (2005) 1.54
Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol (2004) 1.51
Trombone player's lung: a probable new cause of hypersensitivity pneumonitis. Chest (2010) 1.48
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial. Clin Infect Dis (2004) 1.46
Global scale-up of the programmatic management of multidrug-resistant tuberculosis. Indian J Tuberc (2014) 1.43
Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin North Am (2002) 1.43
Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med (2012) 1.41
Use of antisialogogues in bronchoscopy. Chest (2010) 1.38
Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infect Dis (2011) 1.38
Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother (2006) 1.37
Pulsed-field gel electrophoresis study of Mycobacterium abscessus isolates previously affected by DNA degradation. J Clin Microbiol (2004) 1.37
Internet-based patient education and support interventions: a review of evaluation studies and directions for future research. Comput Biol Med (2004) 1.37
Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother (2004) 1.35
First isolations of Segniliparus rugosus from patients with cystic fibrosis. J Clin Microbiol (2007) 1.33
Forty years of disinfectant failure: outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride. Clin Infect Dis (2003) 1.28
Notes from the Field: Mycobacterium chimaera Contamination of Heater-Cooler Devices Used in Cardiac Surgery - United States. MMWR Morb Mortal Wkly Rep (2016) 1.27
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2006) 1.24
Mycobacterium simae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol (2004) 1.21
High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis (2014) 1.21
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. Thorax (2012) 1.21
Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. Am J Respir Crit Care Med (2010) 1.18
Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA. Emerg Infect Dis (2011) 1.16
A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis (2003) 1.15
Diagnosis and treatment of infections due to Mycobacterium avium complex. Semin Respir Crit Care Med (2008) 1.15
Is Internet-based support for dyspnea self-management in patients with chronic obstructive pulmonary disease possible? Results of a pilot study. Heart Lung (2005) 1.14
IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin Immunol (2007) 1.13
Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol (2012) 1.12
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2005) 1.12
Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung (2010) 1.11
Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. Mayo Clin Proc (2011) 1.09
Surgical lung biopsy over bronchoalveolar lavage in chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med (2014) 1.08
Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease. J Immunol (2007) 1.07
In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. J Clin Microbiol (2013) 1.06
Phylogenetic analysis of Mycobacterium aurum and Mycobacterium neoaurum with redescription of M. aurum culture collection strains. Int J Syst Evol Microbiol (2009) 1.05
In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria. Antimicrob Agents Chemother (2003) 1.05
Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS One (2011) 1.04
Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis (2002) 1.04
Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease. Chest (2015) 1.04
Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics. Am J Respir Crit Care Med (2007) 1.02
Mycobacterium abscessus. "Pleased to meet you, hope you guess my name...". Ann Am Thorac Soc (2015) 1.02
Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob Agents Chemother (2002) 1.01
In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease. Antimicrob Agents Chemother (2012) 1.01
Conditions associated with an abnormal nonspecific pattern of pulmonary function tests. Chest (2008) 1.00
A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males. PLoS One (2010) 1.00
Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol (2005) 1.00
You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need. Ann Rheum Dis (2012) 0.99
Mycobacterial interspersed repetitive-unit-variable-number tandem-repeat (MIRU-VNTR) genotyping of mycobacterium intracellulare for strain comparison with establishment of a PCR-based database. J Clin Microbiol (2012) 0.98
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. Int J Antimicrob Agents (2011) 0.95
Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clin Infect Dis (2003) 0.95
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Ann Am Thorac Soc (2014) 0.94
Potential public health impact of new tuberculosis vaccines. Emerg Infect Dis (2004) 0.94
The genome sequence of 'Mycobacterium massiliense' strain CIP 108297 suggests the independent taxonomic status of the Mycobacterium abscessus complex at the subspecies level. PLoS One (2013) 0.94
Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest (2013) 0.93
Alveolar macrophage recruitment and activation by chronic second hand smoke exposure in mice. COPD (2009) 0.92
Tuberculosis in healthcare workers: a molecular epidemiologic study in San Francisco. Infect Control Hosp Epidemiol (2006) 0.91
Effects of treatment on two types of self-efficacy in people with chronic obstructive pulmonary disease. J Pain Symptom Manage (2006) 0.91
Diagnosis of nontuberculous mycobacterial infections. Clin Lab Med (2002) 0.91
Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. J Infect (2007) 0.90
Mycobacterium abscessus: challenges in diagnosis and treatment. Curr Opin Infect Dis (2014) 0.90
Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA. Eur Respir J (2012) 0.90
Five-year outbreak of community- and hospital-acquired Mycobacterium porcinum infections related to public water supplies. J Clin Microbiol (2011) 0.89
Pulmonary resection and lung transplantation for bronchiectasis. Clin Chest Med (2012) 0.88